# Arima Genomics (United States)

**Type:** Institutions  
**Canonical URL:** https://scholariq.org/institutions/arima-genomics-united-states/

## Facts

| Field | Value |
| --- | --- |
| Avg h-index | 33.7 |
| Citations | 10,129 |
| City | San Diego |
| Country | United States |
| Description | Arima Genomics (United States) is a research organisation in San Diego, United States. OpenAlex records 109 works and 10,129 citations for it. 3 researchers list it as their most recent affiliation. |
| Homepage | https://arimagenomics.com/ |
| OpenAlex ID | https://openalex.org/I4210100979 |
| Region | California |
| Researchers | 3 |
| ROR ID | https://ror.org/014a3e682 |
| Type | company |
| Works | 109 |

## University papers

- [Comprehensive genomic characterization of squamous cell lung cancers](https://scholariq.org/papers/comprehensive-genomic-characterization-of-squamous-cell-lung-cancers/)
- [Development and validation of a clinical cancer genomic profiling test based on massively parallel DNA sequencing](https://scholariq.org/papers/development-and-validation-of-a-clinical-cancer-genomic-profiling-test-based-on/)
- [Identification of new ALK and RET gene fusions from colorectal and lung cancer biopsies](https://scholariq.org/papers/identification-of-new-alk-and-ret-gene-fusions-from-colorectal-and-lung-cancer/)
- [Activation of MET via Diverse Exon 14 Splicing Alterations Occurs in Multiple Tumor Types and Confers Clinical Sensitivity to MET Inhibitors](https://scholariq.org/papers/activation-of-met-via-diverse-exon-14-splicing-alterations-occurs-in-multiple/)
- [Establishing guidelines to harmonize tumor mutational burden (TMB): in silico assessment of variation in TMB quantification across diagnostic platforms: phase I of the Friends of Cancer Research TMB Harmonization Project](https://scholariq.org/papers/establishing-guidelines-to-harmonize-tumor-mutational-burden-tmb-in-silico/)
- [Complementary genomic approaches highlight the PI3K/mTOR pathway as a common vulnerability in osteosarcoma](https://scholariq.org/papers/complementary-genomic-approaches-highlight-the-pi3k-mtor-pathway-as-a-common/)
- [Inflammatory Myofibroblastic Tumors Harbor Multiple Potentially Actionable Kinase Fusions](https://scholariq.org/papers/inflammatory-myofibroblastic-tumors-harbor-multiple-potentially-actionable/)
- [<i>BRCA</i> Reversion Mutations in Circulating Tumor DNA Predict Primary and Acquired Resistance to the PARP Inhibitor Rucaparib in High-Grade Ovarian Carcinoma](https://scholariq.org/papers/i-brca-i-reversion-mutations-in-circulating-tumor-dna-predict-primary-and/)

## University researchers

- [Doron Lipson](https://scholariq.org/researchers/doron-lipson/)
- [Elena Helman](https://scholariq.org/researchers/elena-helman/)
- [Siddarth Selvaraj](https://scholariq.org/researchers/siddarth-selvaraj/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.